ARTICLE | Company News
Allergan licenses Spectrum's EOquin
October 30, 2008 12:43 AM UTC
Spectrum (NASDAQ:SPPI) gained $0.47 (49%) to $1.42 on Wednesday after granting Allergan (NYSE:AGN) exclusive worldwide rights, excluding Asia, to develop and commercialize EOquin apaziquone. The analo...